Literature DB >> 23361473

Reply to the letter by Lai et al. regarding "body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal study".

Teruki Miyake, Teru Kumagi, Shinya Furukawa, Masanori Abe, Yoichi Hiasa, Bunzo Matsuura, Morikazu Onji.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23361473     DOI： 10.1007/s00535-012-0735-4

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  5 in total

1.  Metabolic markers and ALT cutoff level for diagnosing nonalcoholic fatty liver disease: a community-based cross-sectional study.

Authors:  Teruki Miyake; Teru Kumagi; Masashi Hirooka; Mitsuhito Koizumi; Shinya Furukawa; Teruhisa Ueda; Yoshio Tokumoto; Yoshio Ikeda; Masanori Abe; Kohichiro Kitai; Yoichi Hiasa; Bunzo Matsuura; Morikazu Onji
Journal:  J Gastroenterol       Date:  2012-02-14       Impact factor: 7.527

2.  Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study.

Authors:  Teruki Miyake; Teru Kumagi; Masashi Hirooka; Shinya Furukawa; Mitsuhito Koizumi; Yoshio Tokumoto; Teruhisa Ueda; Shin Yamamoto; Masanori Abe; Kohichiro Kitai; Yoichi Hiasa; Bunzo Matsuura; Morikazu Onji
Journal:  J Gastroenterol       Date:  2012-08-31       Impact factor: 7.527

3.  Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study.

Authors:  Yuichiro Eguchi; Hideyuki Hyogo; Masafumi Ono; Toshihiko Mizuta; Naofumi Ono; Kazuma Fujimoto; Kazuaki Chayama; Toshiji Saibara
Journal:  J Gastroenterol       Date:  2012-02-11       Impact factor: 7.527

4.  Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.

Authors:  Kittichai Promrat; David E Kleiner; Heather M Niemeier; Elizabeth Jackvony; Marie Kearns; Jack R Wands; Joseph L Fava; Rena R Wing
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

5.  A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff.

Authors:  Noriko Oza; Yuichiro Eguchi; Toshihiko Mizuta; Eriko Ishibashi; Yoichiro Kitajima; Hiroko Horie; Michiko Ushirogawa; Takeko Tsuzura; Shunya Nakashita; Hirokazu Takahashi; Yasunori Kawaguchi; Yasutomo Oda; Ryuichi Iwakiri; Iwata Ozaki; Takahisa Eguchi; Naofumi Ono; Kazuma Fujimoto
Journal:  J Gastroenterol       Date:  2009-09-01       Impact factor: 7.527
  5 in total
  2 in total

1.  Short sleep duration reduces the risk of nonalcoholic fatty liver disease onset in men: a community-based longitudinal cohort study.

Authors:  Teruki Miyake; Teru Kumagi; Shinya Furukawa; Masashi Hirooka; Keitarou Kawasaki; Mitsuhito Koizumi; Yasuhiko Todo; Shin Yamamoto; Yoshio Tokumoto; Yoshio Ikeda; Masanori Abe; Kohichiro Kitai; Bunzo Matsuura; Yoichi Hiasa
Journal:  J Gastroenterol       Date:  2014-08-13       Impact factor: 7.527

2.  Significance of exercise in nonalcoholic fatty liver disease in men: a community-based large cross-sectional study.

Authors:  Teruki Miyake; Teru Kumagi; Masashi Hirooka; Shinya Furukawa; Keitarou Kawasaki; Mitsuhito Koizumi; Yasuhiko Todo; Shin Yamamoto; Hiroaki Nunoi; Yoshio Tokumoto; Yoshio Ikeda; Masanori Abe; Kohichiro Kitai; Bunzo Matsuura; Yoichi Hiasa
Journal:  J Gastroenterol       Date:  2014-04-21       Impact factor: 7.527
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.